Home pageM1CK34 • BVMF
add
McKesson
Chiusura precedente
1128,57Â R$
Intervallo annuale
953,49Â R$ - 1308,54Â R$
Cap di mercato
108,31Â Mld USD
Volume medio
19,00
Rapporto P/E
-
Dividendo/Prezzo
-
Notizie
Dati finanziari
Conto economico
Entrate
Utile netto
| (USD) | dic 2025info | Variazione Y/Y |
|---|---|---|
Entrate | 106,16Â Mld | 11,40% |
Spese di gestione | 2,03Â Mld | 0,10% |
Utile netto | 1,19Â Mld | 34,93% |
Margine di profitto netto | 1,12 | 21,74% |
Utili per azione | 9,34 | 16,31% |
EBITDA | 1,83Â Mld | 32,66% |
Aliquota fiscale effettiva | 23,31% | — |
Stato patrimoniale
Totale attivo
Totale passivo
| (USD) | dic 2025info | Variazione Y/Y |
|---|---|---|
Investimenti cash/breve termine | 2,96Â Mld | 161,63% |
Totale attivo | 84,19Â Mld | 18,44% |
Totale passivo | 84,29Â Mld | 14,24% |
Patrimonio netto totale | -99,00 Mln | — |
Azioni in circolazione | 122,49 Mln | — |
Prezzo/valore contabile | -106,97 | — |
Rendimento delle attività | 4,87% | — |
Rendimento sul capitale | 45,52% | — |
Flusso di cassa
Flusso di cassa netto
| (USD) | dic 2025info | Variazione Y/Y |
|---|---|---|
Utile netto | 1,19Â Mld | 34,93% |
Liquidità di esercizio | 1,23 Mld | 151,70% |
Liquidità da investimenti | -269,00 Mln | -97,79% |
Liquidità da finanziamenti | -2,03 Mld | -256,09% |
Flusso di cassa netto | -1,06Â Mld | 14,08% |
Flusso di cassa libero | 850,62Â Mln | 129,94% |
Informazioni
McKesson Corporation is an American publicly traded company that distributes pharmaceuticals and provides health information technology, medical supplies, and health management tools. The company delivers a third of all pharmaceutical products used or consumed in North America and employs over 80,000 employees. With $308.9 billion in 2024 revenue, it is the ninth-largest company by revenue in the United States and the nation's largest health care company. The company is headquartered in Irving, Texas. It is a component of the S&P 500 and is listed on the New York Stock Exchange, where it is traded under the ticker symbol "MCK".
McKesson provides extensive network of infrastructure for the healthcare industry and was an early adopter of technologies, including barcode scanning for distribution, pharmacy robotics, and RFID tags. The company has been named in a federal lawsuit for profiting from the opioid epidemic in the United States.
Throughout the COVID-19 pandemic, McKesson was a key vaccine distributor, serving as the US government's centralized distributor for hundreds of millions of COVID-19 vaccine doses and ancillary supply kits for over a billion doses. Wikipedia
Fondazione
1833
Sito web
Dipendenti
44.000